Oramed CEO Nadav Kidron Speaks with Nathan Latka about Oramed, oral insulin and more. Listen to the full podcast: The Chinese Gave Him $50M For Orally Delivered Insulin Capsul Idea, Will It Take Off?
Oramed Pharmaceuticals Inc. plans a secondary listing in Tel Aviv “in the next few weeks” to take advantage of an increasing number of Israeli investors seeking new opportunities amid new measures to invigorate the stock market, CEO Nadav Kidron told Bloomberg.
Presentation by Nadav Kidron, CEO Date: May 25, 2017 Time: 4:00 p.m. Location: The David InterContinental Hotel, Tel Aviv
Presentation by Nadav Kidron, CEO Date: May 22, 2017 Time: 9:30 a.m. Location: The Stock Exchange, Tel Aviv
Presentation by Nadav Kidron, CEO Date: May 21, 2017 Time: 12:00 noon Location: David InterContinental Hotel, Tel Aviv
Presentation by Dr. Miriam Kidron, Chief Scientific Officer Date: Tuesday, March 28, 2017 Time: 10:45 a.m. EST Location: Royal Sonesta Boston, Cambridge, MA
Oral insulin to be a game changer: Oramed CEO Nadav Kidron tells CNBC On Squawk Box Asia, Kidron talks about the company's latest offering
Company Presentation by Josh Hexter, Chief Operating Officer Date: Wednesday, February 15, 2017 Time: 4:00 p.m. EST Location: Convene, NYC, Track 1 – Tribeca
Company presentation by Josh Hexter, Chief Operating Officer Date: Monday, February 13, 2017 Time: 11:00 a.m. EST Location: The Waldorf Astoria, New York City, Duke of Windsor Room